查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571739

果凍市場規模、佔有率、趨勢分析報告：按產品、按應用、按地區、細分市場預測，2024-2030

Biosurgery Market Size, Share & Trends Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), By Application (General Surgery, Orthopedic Surgery), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

果凍市場成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球果凍市場預計將達到 358.5 億美元。

預計2024年至2030年該市場將以4.7%的複合年成長率成長。多功能產品的可用性以及由於文明病、肥胖和運動相關損傷的流行而導致的手術數量增加等因素預計將推動成長。果凍產品用於外科手術中的沾黏、傷口密封以及受損骨骼和組織的癒合。

果凍產品用於治療慢性傷口，如燒傷、足部潰瘍、惡性傷口和感染的手術傷口。此外，容易出血過多的患者凝血發生率的增加預計將推動市場成長。此外，預計在預測期內，對出血控制和各種嚴重創傷的需求不斷成長將推動果凍市場的成長。

糖尿病的高盛行率增加了傷口和感染疾病的風險，並產生了對果凍產品的需求。根據美國內科醫師學會統計，2017年全球糖尿病足潰瘍年發生率為6.3%。預計這一因素將在未來幾年推動產品需求。此外，容易患各種慢性疾病的老年人口的增加預計將推動市場的發展。據世界衛生組織 (WHO) 稱，到 2050 年，世界老齡化人口預計將從 2015 年的 9 億增加到 20 億。生物外科在整形外科手術、神經外科和婦科手術等其他外科果凍中的應用預計將推動市場的發展。

果凍市場報告亮點

  • 外科密封劑在果凍市場佔據主導地位，2023 年收益佔有率為 26.9%。此細分市場的成長主要受到由於各種原因進行的手術數量不斷增加的影響。
  • 預計2023年全球生物外科果凍將由一般外科應用領域主導，心血管外科應用領域預計將在2024年至2030年經歷最快的複合年成長率。
  • 北美果凍市場在全球產業中佔據主導地位，2023年佔最大銷售佔有率，達50.1%。
  • 預計亞太地區果凍市場在預測期內將呈現 6.0% 的最快複合年成長率。預計成長率歸因於中國和印度等國家的經濟快速成長、可支配收入水準的提高以及醫療基礎設施的不斷完善。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章果凍市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 果凍市場分析工具
    • 波特的分析
    • PESTEL分析

第4章果凍市場：產品評估與趨勢分析

  • 細分儀表板
  • 果凍市場：2023 年和 2030 年產品變化分析
  • 手術密封劑
  • 止血劑
  • 防沾黏屏障
  • 軟組織附著
  • 骨移植附件
  • 其他

第5章果凍市場：應用估算與趨勢分析

  • 細分儀表板
  • 果凍市場：2023 年和 2030 年應用變化分析
  • 一般外科
  • 整形外科手術
  • 心血管外科
  • 神經外科
  • 其他

第6章果凍市場：區域估計與趨勢分析

  • 2023 年及 2030 年果凍市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Sanofi
    • Baxter
    • INTEGRA LIFESCIENCES
    • Medtronic
    • B. Braun SE
    • Pfizer Inc
    • Stryker
    • Johnson &Johnson Services, Inc
    • BD
    • Artivion, Inc（CryoLife, Inc.）
簡介目錄
Product Code: GVR-3-68038-992-0

Biosurgery Market Growth & Trends:

The global biosurgery market size is anticipated to reach USD 35.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 4.7% from 2024 to 2030. Factors such as the availability of multifunctional products and increasing number of surgeries due to prevalence of lifestyle related disease, obesity, and sports related injuries are projected to drive the growth. Biosurgery products are used in surgical procedures for adhesion or wound sealing and healing damaged bones and tissues.

Biosurgery products are used for the treatment of chronic wounds, such as burns, foot ulcer, malignant wounds, and infected surgical wounds. Furthermore, increasing incidence of blood clotting among patients prone to excessive blood loss is expected to drive the market growth. Moreover, rising need for blood loss management and various severe trauma injuries is expected to drive the growth of biosurgery market over the forecast period.

High prevalence of diabetes increases the risk of wounds and infections, creating requirement for biosurgery products. According to the American College of Physicians, the global annual incidence of diabetic foot ulcer was 6.3% in 2017. This factor is projected to drive the product demand in the forthcoming years. Moreover, rising geriatric population prone to various chronic diseases is expected to propel the market. According to the World Health Organization (WHO), the global aging population is expected to reach 2 billion by 2050, from 900 million in 2015. Application of biosurgery in other surgical procedures, such as orthopedic, neurological, and gynecology surgeries is expected to drive the market.

Biosurgery Market Report Highlights:

  • Surgical sealants dominated the biosurgery market with a revenue share of 26.9% in 2023. The growth of this segment is primarily influenced by the growing number of surgeries performed for various reasons.
  • The general surgery application segment dominated the global industry for biosurgery in 2023 and the cardiovascular surgery application segment is expected to experience the fastest CAGR from 2024 to 2030.
  • North America biosurgery market dominated the global industry and accounted for the largest revenue share of 50.1% in 2023.
  • The Asia-Pacific biosurgery market is anticipated to witness the fastest CAGR of 6.0% during the forecast period. The projected growth rate is attributed to rapid economic growth in countries such as China and India, increasing disposable income levels, and rising healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Biosurgery Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Biosurgery Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Biosurgery Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Biosurgery Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Surgical sealants
    • 4.3.1. Surgical sealants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Hemostatic agents
    • 4.4.1. Hemostatic agents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Adhesion barriers
    • 4.5.1. Adhesion barriers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Soft Tissue Attachments
    • 4.6.1. Soft Tissue Attachments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Bone graft Attachments
    • 4.7.1. Bone graft Attachments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biosurgery Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Biosurgery Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. General surgery
    • 5.3.1. General surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Orthopedic surgery
    • 5.4.1. Orthopedic surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cardiovascular surgery
    • 5.5.1. Cardiovascular surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Neurological surgery
    • 5.6.1. Neurological surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biosurgery Market: Regional Estimates & Trend Analysis

  • 6.1. Biosurgery Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.2. China Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. MEA Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Sanofi
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
      • 7.4.1.5. Strategic Initiatives
    • 7.4.2. Baxter
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
      • 7.4.2.5. Strategic Initiatives
    • 7.4.3. INTEGRA LIFESCIENCES
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
      • 7.4.3.5. Strategic Initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
      • 7.4.4.5. Strategic Initiatives
    • 7.4.5. B. Braun SE
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
      • 7.4.5.5. Strategic Initiatives
    • 7.4.6. Pfizer Inc
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
      • 7.4.6.5. Strategic Initiatives
    • 7.4.7. Stryker
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
      • 7.4.7.5. Strategic Initiatives
    • 7.4.8. Johnson & Johnson Services, Inc
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
      • 7.4.8.5. Strategic Initiatives
    • 7.4.9. BD
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
      • 7.4.9.5. Strategic Initiatives
    • 7.4.10. Artivion, Inc (CryoLife, Inc.)
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
      • 7.4.10.5. Strategic Initiatives